Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Effectiveness Study of Imiquimod Creams for the Treatment of Actinic Keratoses (AKs)

ClinicalTrials.gov ID: NCT00603798

Public ClinicalTrials.gov record NCT00603798. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 4:49 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-blinded, Placebo-controlled, Multicenter, Efficacy and Safety Study of Six Weeks of Treatment With Imiquimod Creams for Actinic Keratoses

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine whether imiquimod creams are effective in treating Actinic Keratoses when applied to the face or balding scalp. Actinic keratosis (AK) is a skin condition that shows up on skin routinely exposed to the sun, such as the face, scalp, shoulders, chest, back, arms, and hands. The active ingredient contained in the study cream for this study is the same as that of the approved product Aldara, which has shown to be safe and effective for the treatment of AKs.

Study identification

NCT ID
NCT00603798
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Graceway Pharmaceuticals, LLC
Industry
Enrollment
490 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2008 (Type not available)
Primary completion
Jul 2008 (Actual)
Completion
Jul 2008 (Actual)
Last update posted
Jun 29, 2010

2008

United States locations

U.S. sites
26
U.S. states
16
U.S. cities
25
Facility City State ZIP Site status
Not listed Birmingham Alabama 35205 —
Not listed Little Rock Arkansas 72205 —
Not listed Encino California 91436 —
Not listed Vista California 92083 —
Not listed New Britain Connecticut 06052 —
Not listed New Haven Connecticut 06511 —
Not listed Coral Gables Florida 33134 —
Not listed West Palm Beach Florida 33401 —
Not listed Arlington Heights Illinois 60005 —
Not listed Champaign Illinois 61820 —
Not listed Carmel Indiana 46032 —
Not listed Evansville Indiana 47713 —
Not listed South Bend Indiana 46617 —
Not listed Louisville Kentucky 40202 —
Not listed Omaha Nebraska 68144 —
Not listed Reno Nevada 89509 —
Not listed Albuquerque New Mexico 87106 —
Not listed Portland Oregon 97223 —
Not listed Philadelphia Pennsylvania 19034 —
Not listed Nashville Tennessee 37203 —
Not listed Dallas Texas 75246 —
Not listed Houston Texas 77030 —
Not listed Houston Texas 77058 —
Not listed San Antonio Texas 78229 —
Not listed Norfolk Virginia 23507 —
Not listed Woodbridge Virginia 22191 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00603798, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 29, 2010 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00603798 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →